Literature DB >> 24332996

The impact of switching to the new global lung function initiative equations on spirometry results in the UK CF registry.

Sanja Stanojevic1, Janet Stocks2, Vassiliki Bountziouka2, Paul Aurora3, Jane Kirkby3, Stephen Bourke4, Siobhán B Carr5, Elaine Gunn6, Ammani Prasad7, Margaret Rosenfeld8, Diana Bilton6.   

Abstract

BACKGROUND: The Quanjer et al. Global Lung Function Initiative (GLI)-2012 multi-ethnic all-age reference equations for spirometry are endorsed by all major respiratory societies and are the new gold standard. Before the GLI equations are implemented for use in CF patients, the impact of changing equations from those currently used needs to be better understood.
METHODS: Annual review data submitted to the UK CF Trust Registry between 2007 and 2011 were used to calculate %predicted FEV1, FVC and FEV1/FVC using three widely used reference equations (Wang-Hankinson and Knudson) and the new GLI-2012 equations.
RESULTS: Overall, Knudson and Wang equations overestimated %predicted values in paediatric patients, such that a greater proportion of patients had lung function values in the normal range. Within individual patients, the impact of switching equations varied greatly depending on the patients' age, and which equations were used.
CONCLUSIONS: A unified approach to interpreting spirometric lung function measurements would help facilitate more appropriate comparison both within and between centres and countries. Interpretation of longitudinal measurements using a continuous reference equation across all-ages, like the GLI, may further improve our understanding of CF lung disease.
Copyright © 2013 European Cystic Fibrosis Society. Published by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Cystic fibrosis; Reference values; Spirometry

Mesh:

Year:  2013        PMID: 24332996     DOI: 10.1016/j.jcf.2013.11.006

Source DB:  PubMed          Journal:  J Cyst Fibros        ISSN: 1569-1993            Impact factor:   5.482


  9 in total

1.  Early detection of lung function decrements in children and adolescents with cystic fibrosis using new reference values.

Authors:  Angela Zacharasiewicz; Sabine Renner; Flora Haderer; Michael Weber; Eleonore Dehlink; Zsolt Szepfalusi; Thomas Frischer
Journal:  Wien Klin Wochenschr       Date:  2017-03-09       Impact factor: 1.704

2.  Early Detection of Rapid Cystic Fibrosis Disease Progression Tailored to Point of Care: A Proof-of-Principle Study.

Authors:  Rhonda Szczesniak; Cole Brokamp; Weiji Su; Gary L McPhail; John Pestian; John P Clancy
Journal:  Health Innov Point Care Conf       Date:  2017-12-21

Review 3.  [New international reference values for spirometry: implications for clinical issues using a comparative analysis of a paediatric population].

Authors:  Christiane Lex; Insa Korten; Alexander Hofmann; Sabine Renner; Zsolt Szepfalusi; Thomas Frischer; Angela Zacharasiewicz
Journal:  Wien Med Wochenschr       Date:  2015-09-16

4.  Improvements in lung function and height among cohorts of 6-year-olds with cystic fibrosis from 1994 to 2012.

Authors:  Donald R VanDevanter; David J Pasta; Michael W Konstan
Journal:  J Pediatr       Date:  2014-08-16       Impact factor: 4.406

5.  Phenotypes of Rapid Cystic Fibrosis Lung Disease Progression during Adolescence and Young Adulthood.

Authors:  Rhonda D Szczesniak; Dan Li; Weiji Su; Cole Brokamp; John Pestian; Michael Seid; John P Clancy
Journal:  Am J Respir Crit Care Med       Date:  2017-08-15       Impact factor: 21.405

6.  Data Resource Profile: The UK Cystic Fibrosis Registry.

Authors:  David Taylor-Robinson; Olia Archangelidi; Siobhán B Carr; Rebecca Cosgriff; Elaine Gunn; Ruth H Keogh; Amy MacDougall; Simon Newsome; Daniela K Schlüter; Sanja Stanojevic; Diana Bilton
Journal:  Int J Epidemiol       Date:  2018-02-01       Impact factor: 7.196

Review 7.  Lower airway clinical outcome measures for use in primary ciliary dyskinesia research: a scoping review.

Authors:  Florian Gahleitner; James Thompson; Claire L Jackson; Jana F Hueppe; Laura Behan; Eleonora Dehlink; Myrofora Goutaki; Florian Halbeisen; Ana Paula L Queiroz; Guillaume Thouvenin; Claudia E Kuehni; Philipp Latzin; Jane S Lucas; Bruna Rubbo
Journal:  ERJ Open Res       Date:  2021-11-29

8.  An Animated Functional Data Analysis Interface to Cluster Rapid Lung Function Decline and Enhance Center-Level Care in Cystic Fibrosis.

Authors:  Jesse Pratt; Weiji Su; Don Hayes; John P Clancy; Rhonda D Szczesniak
Journal:  J Healthc Eng       Date:  2021-05-10       Impact factor: 2.682

9.  Using different methods to process forced expiratory volume in one second (FEV 1) data can impact on the interpretation of FEV 1 as an outcome measure to understand the performance of an adult cystic fibrosis centre: A retrospective chart review.

Authors:  Zhe Hui Hoo; Muhaned S A El-Gheryani; Rachael Curley; Martin J Wildman
Journal:  F1000Res       Date:  2018-06-01
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.